outcome

Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol

Kinkel RP, Dontchev M, Kollman C, Skaramagas TT, O'Connor PW, Simon JH. Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol. Archives Neurology. 2012;69(2):183-90. DOI: 10.1001/archneurol.2011.1426. PubMed PMID: 21987393.

Immunological markers of optimal response to natalizumab in multiple sclerosis.

Villar LM, García-Sánchez MI, Costa-Frossard L, Espiño M, Roldán E, Páramo D, et al.. Immunological markers of optimal response to natalizumab in multiple sclerosis. Archives Neurology. 2012;69(2):191-7. DOI: 10.1001/archneurol.2011.971. PubMed PMID: 22332187.

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.

Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, et al. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Archives Neurology. 2012;69(2):198-207. DOI: 10.1001/archneurol.2011.1538. PubMed PMID: 21987394.

Archetypal and new families with Alexander disease and novel mutations in GFAP.

Messing A, Li R, Naidu S, Taylor JP, Silverman L, Flint D, et al. Archetypal and new families with Alexander disease and novel mutations in GFAP. Archives Neurology. 2012;69(2):208-14. DOI: 10.1001/archneurol.2011.1181. PubMed PMID: 21987397.

Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.

Small GW, Siddarth P, Kepe V, Ercoli LM, Burggren AC, Bookheimer SY, et al. Prediction of cognitive decline by positron emission tomography of brain amyloid and tau. Archives Neurology. 2012;69(2):215-22. DOI: 10.1001/archneurol.2011.559. PubMed PMID: 22332188.

Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.

Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Archives Neurology. 2012;69(2):223-9. DOI: 10.1001/archneurol.2011.666. PubMed PMID: 22332189.

Stiff-man syndrome and variants: clinical course, treatments, and outcomes.

McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Archives Neurology. 2012;69(2):230-8. DOI: 10.1001/archneurol.2011.991. PubMed PMID: 22332190.

Failure of natalizumab to prevent relapses in neuromyelitis optica.

Kleiter I, Hellwig K, Berthele A, Kümpfel T, Linker RA, Hartung H-P, et al.. Failure of natalizumab to prevent relapses in neuromyelitis optica. Archives Neurology. 2012;69(2):239-45. DOI: 10.1001/archneurol.2011.216. PubMed PMID: 22332191.

Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.

Moghekar A, Goh J, Li M, Albert M, O'Brien RJ. Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort. Archives Neurology. 2012;69(2):246-50. DOI: 10.1001/archneurol.2011.732. PubMed PMID: 22332192; PubMed Central PMCID: PMC3310240.

Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study.

Gardener H, Scarmeas N, Gu Y, Boden-Albala B, Elkind MSV, Sacco RL, et al. Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study. Archives Neurology. 2012;69(2):251-6. DOI: 10.1001/archneurol.2011.548. PubMed PMID: 22332193; PubMed Central PMCID: PMC3281550.